.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Deloitte
Queensland Health
US Army
Cerilliant
Chubb
Boehringer Ingelheim
Cipla
Moodys

Generated: December 13, 2017

DrugPatentWatch Database Preview

MPI INDIUM DTPA IN 111 Drug Profile

« Back to Dashboard

When do Mpi Indium Dtpa In 111 patents expire, and when can generic versions of Mpi Indium Dtpa In 111 launch?

Mpi Indium Dtpa In 111 is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in MPI INDIUM DTPA IN 111 is indium in-111 pentetate disodium. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the indium in-111 pentetate disodium profile page.

Summary for MPI INDIUM DTPA IN 111

Drug patent expirations by year for MPI INDIUM DTPA IN 111

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ge HealthcareMPI INDIUM DTPA IN 111indium in-111 pentetate disodiumINJECTABLE;INTRATHECAL017707-001Feb 18, 1982RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
McKesson
Citi
Deloitte
Queensland Health
Cipla
Teva
QuintilesIMS
Federal Trade Commission
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot